I hope there is no cattle involved in reselling Ambit/Acromed pumps.
I think the RAH capital sales was $4m, this year they have been working to convert the $4m decrease in capital sales with consumable sales, from the Nov AGM it was indicated that the Ambit business was growing 24% yoy and Acromed was flat.
Perhaps there is nothing huge to worry about, worst case $4m per year revenue downgrade ($2m profit with 48% GM).
So worst case $1m per quarter in revenue and $500k per quarter in profit downgrade?
I hope there is no cattle involved in reselling Ambit/Acromed...
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.30 |
Change
0.300(1.67%) |
Mkt cap ! $351.7M | |||
| Open | High | Low | Value | Volume |
| $18.25 | $18.30 | $18.01 | $12.33K | 679 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 300 | $18.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.30 | 247 | 2 |
View Market Depth
| Last trade - 14.56pm 04/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |